# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T00:46:37.235398
**Route:** OpenRouter + LaTeX
**Tokens:** 25779 in / 1823 out
**Response SHA256:** 4b007599671a072e

---

I checked the manuscript for the specific classes of FATAL errors you asked me to screen for (data-design alignment, regression sanity, completeness, internal consistency). I focused only on the prohibited/fatal issues (not style, contribution, or minor choices).

Summary judgment: I found no fatal errors.

Notes from my check (brief, focused on possible red flags I verified):

- Data-design alignment
  - Treatment timing vs data coverage: The paper states the mortality data cover 1999–2017 (NCHS final) and 2020–2023 (CDC provisional), and that treated cohorts with first treatment year ≤ 2023 are used as treated. The latest treatment year used in estimation is 2023 (they explicitly list 2023 cohorts). Thus max(treatment year) ≤ max(data year) holds (2023 ≤ 2023). The authors explicitly reclassify 2024–2025 adopters and Vermont (suppressed post-period) as not-yet-treated / first_treat = 0 so they do not require post-treatment outcomes. That reclassification is stated consistently throughout.
  - Post-treatment observations: The paper documents which states lack post-2020 cells due to suppression and explains how those states are handled (reclassified as not-yet-treated or contribute only pre-period). The Callaway–Sant’Anna estimator is used with allow_unbalanced_panel = TRUE, which accommodates the missing cells. The authors acknowledge the 2018–2019 gap and the implication for event-study proximity; they map event times accordingly. I see no impossible claim that would require unavailable years.
  - Treatment definition consistency: The policy timing convention is clearly defined (first full calendar year of exposure, month cutoff rule), and the cohort tables and narrative are consistent with that convention (cohorts listed and counted consistently).

- Regression sanity
  - Reported coefficients and standard errors in the text are plausible in scale for the outcome (diabetes mortality per 100k): e.g., CS-ATT 1.524 (SE 1.260), TWFE -0.242 (SE 1.963). No reported SEs or coefficients in the text violate the sanity rules you specified (no enormous SEs, no |coef| > 100, no R² outside [0,1], no "NA"/"Inf" reported).
  - The paper documents use of appropriate clustered/semi-robust inference (multiplier bootstrap for CS-DiD, cluster-robust, CR2, and wild cluster bootstrap for TWFE) and reports p-values and CIs. Nothing in the text indicates broken regression output.
  - The authors note a diagonal approximation in the HonestDiD implementation (and explicitly discuss its conservatism); this is flagged transparently (not a fatal error).

- Completeness
  - The paper reports the analysis panel size in the text and Table: 1,157 state-year observations (969 pre-period + 188 provisional post-period) and shows the arithmetic. The panel construction is documented step-by-step (including suppressed cells). The cohort composition table and other appendices enumerate states and sample composition.
  - Placeholders (NA, TBD, TODO, XXX, “Sun-Abraham NA NA”, empty cells) do not appear in the visible source. The draft repeatedly references \input{tables/...} and \input{figures/...} which is standard LaTeX practice; the main text reports numeric results (estimates, SEs, Ns) rather than placeholders.
  - Required elements: the paper reports sample size for the panel, reports standard errors and CIs, documents which estimators and inference procedures are used, and contains extensive robustness checks. The appendices describe variable definitions, estimation settings, and cohort lists. I did not find missing references to figures/tables that do not exist; figures/tables referenced appear described and enumerated.

- Internal consistency
  - Numbers described in the text (panel counts, cohort counts, main point estimates, SEs, CIs) are internally consistent across sections and appendices (e.g., 17 treated states enumerated sum correctly across cohort counts; panel arithmetic matches 51×19 and 51×4 minus suppressed cells).
  - Treatment timing, cohort assignments, and how not-yet-treated states are coded are described consistently (first_treat = 0 for never-treated and not-yet-treated is explicitly stated and used throughout).
  - Specification descriptions match column labels in text (TWFE, CS-DiD, Sun–Abraham) and the accompanying inference statements are coherent.

Because you asked for only fatal errors, I did not comment on writing quality, minor statistical choices, or contribution. If you want a more granular list of non-fatal suggestions (e.g., power calculation details, potential additional robustness checks, or places to strengthen explanations), I can provide that separately.

Final required line:

ADVISOR VERDICT: PASS